XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 291.74%110.07M | -188.12%-127.53M | 300.95%60.93M | 212.61%82.85M | -13.09%79.75M | 82.51%-57.41M | -115.83%-44.26M | 65.99%-30.32M | -446.43%-73.57M | 180.33%91.77M |
Net income from continuing operations | -57.21%5.97M | -55.66%8.42M | -55.97%69.03M | -26.23%30.94M | -85.68%5.15M | -58.45%13.96M | -58.04%18.98M | 17.80%156.77M | 11.92%41.94M | -4.12%36M |
Operating gains losses | 410.17%2.41M | 78.66%-578K | -64.70%-20.71M | -228.92%-17.43M | 194.29%206K | 83.36%-777K | -1.20%-2.71M | -82.08%-12.58M | -104.63%-5.3M | 104.35%70K |
Depreciation and amortization | 65.03%4.64M | 68.66%4.71M | -9.01%11.4M | 3.79%2.85M | -11.71%2.95M | -13.77%2.81M | -12.31%2.79M | -54.12%12.53M | -14.96%2.74M | -55.75%3.34M |
Deferred tax | ---- | ---- | -269.72%-2.69M | ---- | ---- | ---- | ---- | 138.60%1.59M | ---- | ---- |
Other non cash items | -188.12%-445K | 102.08%1.75M | 16.50%2.28M | -8.98%527K | 310.44%383K | -51.77%505K | 68.48%866K | -31.68%1.96M | -26.71%579K | -134.60%-182K |
Change In working capital | 230.65%97.19M | -118.52%-142.32M | 99.52%-939K | 158.62%68.06M | 35.59%70.51M | 79.45%-74.39M | -128.04%-65.13M | 20.99%-193.74M | -111.29%-116.11M | 133.02%52M |
-Change in receivables | 526.73%40.23M | -4,499.46%-40.83M | -73.24%16.81M | -37.75%34.67M | -144.20%-9.36M | -1,415.59%-9.43M | 106.90%928K | 1,581.00%62.81M | 311.26%55.69M | 42.13%21.18M |
-Change in inventory | 182.93%91.04M | -1,335.87%-185.44M | 73.55%-49.29M | 286.26%29.13M | 478.60%44.27M | 64.01%-109.78M | -108.85%-12.92M | 10.40%-186.39M | -150.57%-15.64M | 94.29%-11.69M |
-Change in prepaid assets | -8.87%678K | -12.41%-987K | 64.99%-1.17M | 114.88%275K | 29.59%-1.31M | -64.72%744K | 49.48%-878K | -414.02%-3.34M | -245.05%-1.85M | -63.79%-1.86M |
-Change in payables and accrued expense | 480.43%4.6M | 51.15%-12.12M | -228.40%-24.37M | -103.68%-618K | -96.01%261K | 102.79%792K | -203.30%-24.8M | 1,040.85%18.98M | 183.56%16.78M | -71.04%6.55M |
-Change in other current assets | -74.31%15.88M | 161.90%6M | -361.46%-36.24M | -328.78%-83.29M | 69.47%-5.09M | 766.18%61.83M | -116.36%-9.69M | 129.36%13.86M | 70.47%-19.43M | -1,238.80%-16.67M |
-Change in other current liabilities | -517.48%-45.84M | 115.58%26.79M | 126.68%28.14M | 75.63%-19.33M | 196.35%24.07M | 193.32%10.98M | 17.10%12.43M | -394.70%-105.48M | -286.29%-79.34M | -10.65%-24.98M |
-Change in other working capital | 68.16%-9.4M | 312.86%64.27M | 1,020.32%65.18M | 248.26%107.23M | -77.77%17.67M | -228.78%-29.52M | -495.31%-30.19M | 130.83%5.82M | -312.44%-72.33M | 128.95%79.48M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 291.74%110.07M | -188.12%-127.53M | 300.95%60.93M | 212.61%82.85M | -13.09%79.75M | 82.51%-57.41M | -115.83%-44.26M | 65.99%-30.32M | -446.43%-73.57M | 180.33%91.77M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 51.30%-4.98M | 3,717.06%15.48M | -1,029.92%-63.6M | 38.34%-5.09M | -398,841.67%-47.85M | 53.57%-10.23M | -101.15%-428K | 111.29%6.84M | 58.41%-8.25M | 100.08%12K |
Capital expenditure reported | -90.97%-3.7M | 67.82%-607K | -51.70%-7.26M | -75.96%-2.74M | -22.83%-694K | -11.70%-1.94M | -103.45%-1.89M | -66.13%-4.78M | -101.29%-1.56M | -17.95%-565K |
Net intangibles purchase and sale | ---- | ---- | -70.30%-8.52M | --0 | ---8.52M | ---- | ---- | ---5M | -300.00%-500K | --0 |
Net business purchase and sale | ---- | ---- | ---31.87M | --1.02M | ---- | ---- | ---- | --0 | --0 | ---- |
Net investment purchase and sale | ---- | ---- | 74.51%-2.11M | --0 | 59.07%-2.06M | ---- | ---- | 79.40%-8.29M | 91.79%-2.75M | ---5.04M |
Net other investing changes | 82.22%-1.47M | 1,003.43%16.09M | -155.56%-13.84M | 2.29%-3.37M | -165.68%-3.69M | 47.82%-8.24M | -96.22%1.46M | 242.89%24.91M | -124.31%-3.45M | 137.27%5.62M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 51.30%-4.98M | 3,717.06%15.48M | -1,029.92%-63.6M | 38.34%-5.09M | -398,841.67%-47.85M | 53.57%-10.23M | -101.15%-428K | 111.29%6.84M | 58.41%-8.25M | 100.08%12K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -338.58%-114.25M | 105.79%110.34M | -52.11%11.98M | -249.37%-64.29M | 70.72%-25.23M | -86.63%47.89M | 118.50%53.62M | -70.94%25.02M | 1.18%43.04M | -161.89%-86.18M |
Net issuance payments of debt | -79.03%-114.68M | 159.99%90.33M | -496.94%-81.55M | -1,286.40%-45M | 57.41%-7.24M | -135.22%-64.06M | 123.46%34.74M | -31.52%20.55M | 109.48%3.79M | -117.89%-17M |
Net common stock issuance | 57.45%-5.12M | --0 | -128.51%-22.31M | --0 | 44.98%-5.37M | ---12.03M | ---4.9M | ---9.76M | --0 | ---9.76M |
Cash dividends paid | 0.21%-4.64M | 83.47%-4.63M | -11.68%-41.85M | 2.01%-4.58M | 2.70%-4.58M | 0.89%-4.65M | -19.83%-28.03M | -65.46%-37.47M | -77,800.00%-4.67M | ---4.71M |
Proceeds from stock option exercised by employees | --0 | 241.77%3.28M | 4.14%1.96M | 44.66%664K | -52.00%336K | -99.70%2K | 1,423.81%960K | -18.90%1.88M | 45.25%459K | 18.04%700K |
Net other financing activities | -92.08%10.19M | -58.00%21.36M | 212.57%155.72M | -135.38%-15.38M | 84.88%-8.38M | -28.62%128.62M | 142.94%50.85M | -34.82%49.82M | -47.14%43.46M | -226.97%-55.41M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -338.58%-114.25M | 105.79%110.34M | -52.11%11.98M | -249.37%-64.29M | 70.72%-25.23M | -86.63%47.89M | 118.50%53.62M | -70.94%25.02M | 1.18%43.04M | -161.89%-86.18M |
Net cash flow | ||||||||||
Beginning cash position | -2.74%46.92M | 23.70%48.64M | 4.06%39.32M | -54.97%35.17M | -60.70%28.5M | -25.36%48.25M | 4.06%39.32M | -62.74%37.78M | 173.57%78.1M | 274.63%72.5M |
Current changes in cash | 53.64%-9.16M | -119.18%-1.71M | 507.04%9.32M | 134.73%13.47M | 19.10%6.67M | -351.14%-19.75M | -66.75%8.93M | 102.41%1.54M | -520.00%-38.78M | -39.09%5.6M |
End cash Position | 32.54%37.77M | -2.74%46.92M | 23.70%48.64M | 23.70%48.64M | -54.97%35.17M | -60.70%28.5M | -25.36%48.25M | 4.06%39.32M | 4.06%39.32M | 173.57%78.1M |
Free cash flow | 279.08%106.27M | -177.66%-128.14M | 212.61%45.16M | 205.93%80.11M | -22.65%70.54M | 82.25%-59.34M | -116.56%-46.15M | 56.43%-40.11M | -440.70%-75.63M | 179.33%91.2M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |